MCCOURT MARION (SVP Commercial) sold 16.3% of their position (2.35K shares) of REGENERON PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $2.00M — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 9/3/2026ACC: 0001663758-26-000002
Officer· SVP Commercial
Since Dec 2018
-2.35K
Net shares
Net seller
$2.00M
Total sold
2
Open market trades
0B · 2S
2
Total transactions
2.35K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−1.22K
Price / share
$850.00
Trade value
$1.03M
% of position
8.5%
9/2/2026
14.35K→13.13K
Common Stock
Direct
Shares
−1.13K
Price / share
$857.39
Trade value
$969.71K
% of position
8.6%
9/3/2026
13.13K→12K
Total
Net shares
−2.35K
Net value
-$2M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/2/2026 | S · Sale | −1.22K | $850.00 | $1.03M | 8.5% | 14.35K | 13.13K |
| Common Stock Direct | 9/3/2026 | S · Sale | −1.13K | $857.39 | $969.71K | 8.6% | 13.13K | 12K |
| Total | −2.35K | -$2M | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned219.00
Total
219.00 indirect219.00
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 219.00 | Indirect |
| Total | 219.00 | 219.00 indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported